Community Academic Profiles

Charles DeBattista

Publication Details

  • Mifepristone versus placebo in the treatment of psychosis in patients with psychotic major depression.

    DeBattista C, Belanoff J, Glass S, Khan A, Horne RL, Blasey C, Carpenter LL, Alva G. Biol Psychiatry. 2006; 60 (12): 1343-9

    Abnormalities in the hypothalamic pituitary adrenal axis have been implicated in the pathophysiology of psychotic major depression (PMD). Recent studies have suggested that the antiglucocorticoid, mifepristone might have a role in the treatment of PMD. The current study tested the efficacy of mifepristone treatment of the psychotic symptoms of PMD.

    PubMedID: 16889757

Stanford Medicine Resources: